
Renchen Bio
壬辰生物
Renchen Bio
Biotech/Healthcare
Founded in 2020, Renchen Biotech discovered and validated novel biomarkers associated with the screening and diagnosis of preterm birth and preeclampsia. It also achieved highly efficient and precise capture and isolation of human trophoblast stem cells, enabling reliable, noninvasive early…
Latest round: Angel (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.